Updated on 2025/04/17

写真a

 
LI JUNJIE
 
Organization
Institute for Materials Chemistry and Engineering Department of Soft Materials Chemistry Associate Professor
Title
Associate Professor
Contact information
メールアドレス
Tel
928026238
External link

Degree

  • PhD

Awards

  • 日韓バイオマテリアル学会若手研究者交流AWARD

    2023.7   Japanese and Korean Biomaterials Societies Young Scientist Exchange Program Award

  • CASNNベストポスター賞、中国アメリカン・ナノメディシン・ナノテクノロジー学会年次大会

    2019.8   CASNN Best Poster Award, Chinese American Society of Nanomedicine and Nanobiotechnology 2019 Annual Conference

  • 日本学術振興会特別研究員

    2017.8   JSPS Postdoctoral Fellowship

  • 中国科学技術大学優秀卒業生

    2017.6   Outstanding graduate of University of Science and Technology of China

  • 中国科学技術大学大学院生国家奨学金

    2013.10   National Scholarship for Graduate Student in University of Science and Technology of China

Papers

  • Leveraging Adrenergic Receptor Blockade for Enhanced Nonalcoholic Fatty Liver Disease Treatment via a Biomimetic Nanoplatform

    2024.5

  • Editorial: Delivery systems in biologics-based therapeutics

    Anjaneyulu Dirisala, Junjie Li, Daniel Gonzalez-Carter, Zheng Wang

    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY   11   2023.8

     More details

    Language:English  

    DOI: 10.3389/fbioe.2023.1274210

  • Stealth and pseudo-stealth nanocarriers Invited Reviewed

    Panyue Wen, Wendong Ke, Anjaneyulu Dirisala, Kazuko Toh, Masaru Tanaka, Junjie Li

    Advanced Drug Delivery Reviews   114895 - 114895   2023.5

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.addr.2023.114895

  • Targeted nanomedicine in cisplatin-based cancer therapeutics

    Yu Han, Panyue Wen, Junjie Li, Kazunori Kataoka

    Journal of Controlled Release   345   709 - 720   2022.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Since its license in 1978, cisplatin has proved to be one of the most successful chemotherapeutic agents in the world. However, two acute challenges facing cisplatin, resistance and toxicity, have resulted in a bottleneck of clinical application. Targeted nanomedicine shows great promise in delivering cisplatin for maximizing efficacy while minimizing off-target toxicity. This article surveyed the recent progress and challenges of targeted nanomedicine in managing resistance and toxicity of cisplatin in both fundamental and clinical aspects. Particularly, we focused on three major mechanisms counteracting cisplatin sensitivity (decreased intracellular accumulation, increased cisplatin deactivation, and enhanced DNA repair/translesion synthesis) and correspondingly highlighted a few representative approaches to increase cisplatin sensitivity through improving the intracellular concentration of cisplatin and implementing combination therapy. Moreover, the requirements for future advancements in cisplatin delivery systems are rendered with emphasis on (i) understanding of nano-bio interaction and post-accumulation biological effects instead of overwhelmingly improving tumor accumulation, (ii) development of stimuli-responsive and/or actively-targeted nanomedicines, (iii) optimization of combination therapy, (iv) novel combinations targeting tumor microenvironment and immunotherapy. We postulate that cisplatin-based nanomedicines will continuously advance and potentially revolutionize oncological treatment.

    DOI: 10.1016/j.jconrel.2022.03.049

  • Effective mRNA Protection by Poly(L‐Ornithine) Synergizes with Endosomal Escape Functionality of a Charge‐Conversion Polymer Toward Maximizing mRNA Introduction Efficiency Reviewed

    Anjaneyulu Dirisala, Satoshi Uchida, Junjie Li, Joachim F. R. Van Guyse, Kotaro Hayashi, Sai V. C. Vummaleti, Sarandeep Kaur, Yuki Mochida, Shigeto Fukushima, Kazunori Kataoka

    Macromolecular Rapid Communications   2100754 - 2100754   2022.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/marc.202100754

▼display all

Books

  • Thermo-responsive polyplex micelles with PEG shells and PNIPAM layer to protect DNA cores for systemic gene therapy

    リージェンジェ(Role:Sole author)

    Humana Press, New York, NY 

     More details

    Language:English  

    Thermo-responsive polyplex micelles with PEG shells and PNIPAM layer to protect DNA cores for systemic gene therapy https://link.springer.com/protocol/10.1007/978-1-4939-3718-9_17

Presentations

  • Enzyme-responsive asymmetric polymersomes with triggered apoptosis-mimicking flip-flop of cell-penetrating inner shells International conference

    リージェンジェ

    4th Symposium on Innovative Polymers for Controlled Delivery (SIPCD 2016)  2016.9 

     More details

    Language:English  

    Country:Other  

    Enzyme-responsive asymmetric polymersomes with triggered apoptosis-mimicking flip-flop of cell-penetrating inner shells

  • Novel stimuli-responsive block copolymers as nonviral gene delivery vectors for efficiently overcoming physiologic barriers International conference

    リージェンジェ

    the 1st International Conference on Nanomedicine (ChinaNanomedicine 2015, Hangzhou, China)  2016.2 

     More details

    Language:English  

    Country:Other  

    Novel stimuli-responsive block copolymers as nonviral gene delivery vectors for efficiently overcoming physiologic barriers

MISC

  • Enzyme-responsive asymmetric polymersomes with triggered apoptosis-mimicking flip-flop of cell-penetrating inner shells

    Junjie Li, Zhishen Ge

    JOURNAL OF CONTROLLED RELEASE   2017.8

     More details

    Language:English  

    DOI: 10.1016/j.jconrel.2017.03.380

  • Novel stimuli-responsive block copolymers as nonviral gene delivery vectors for efficiently overcoming physiologic barriers

    Zhishen Ge, Junjie Li, Yang Li

    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE   2016.2

     More details

    Language:English  

    DOI: 10.1016/j.nano.2015.12.238

Research Projects

  • Development of Reversible Double-Layer Polymer Modification Technology to Break the Safety/Efficacy Trade-Off of Delivering Enzyme

    Grant number:23H03740  2023 - 2025

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

Notable Clinical Activities

  • 該当しない